Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 0kWORD 0k
12 April 2018
P-000682/2018(ASW)
Answer given by President Juncker on behalf of the Commission
Question reference: P-000682/2018

1-2. In the margins of the European Council (Article 50) of 22 June 2017, the 27 Member States endorsed a procedure leading up to a decision on the relocation of the United Kingdom (UK)-based agencies(1). Under this procedure the Commission was asked to examine the offers submitted by the Member States' to host one or both of the agencies.

According to the procedure, Member States had the possibility to request that business secrets and other confidential information contained in their offers would not be published. The Commission received from the Secretary-General of the Council both the public and the confidential versions of the offers in order to make its assessment which it submitted on 30 September 2017(2).

The EU-27 ministers voted on the relocation of the European Medicines Agency in the margins of the General Affairs Council (Article 50) meeting on 20 November 2017. In accordance with the procedure, on 29 November 2017, the Commission adopted a legislative proposal confirming the selection of Amsterdam as the agency's new seat. As explained in President Juncker's letter of 23 February 2018 to President Tajani, all documents, including the offers and the Commission's assessment, have been made publicly available on a dedicated website of the European Council(3). Although the Commission does not consider the confidential version of the Netherlands's offer relevant for the legislative procedure, it notes that it is now available on the European Council website.

3. The Government of the Netherlands has confirmed that it will cover the costs related to the temporary premises of the agency. Consequently, the costs entailed by the occupation of this building will have no impact on the EU budget. As regards the permanent building, on 2 March 2018 the agency transmitted a building file to the Budgetary Authority, as prescribed by Article 203 of the Financial Regulation.

(1)http://www.consilium.europa.eu/en/policies/relocation-london-agencies-brexit/
(2)The Commission’s methodology for assessing the Member States' offers to host one or both of the UK-based EU agencies is clearly set out in its Note of September 2017: https://ec.europa.eu/info/sites/info/files/commission-assessment-cover-note.pdf
(3)http://www.consilium.europa.eu/media/32783/annex-to-the-dutch-offer-for-ema.pdf

Last updated: 13 April 2018Legal notice